Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
FTK · NYSE · United States · Miscellaneous Chemical Products
In shortFLOTEK INDUSTRIES INC/CN/ is profitable, generates cash and carries moderate debt, with revenue growing (+26.9% last year).
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 9.8% | 49/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 12.9% | 71/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 26.9% | 100/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 12.0% | 80/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.80× | 83/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.35× | 91/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.37× | 75/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 5.90× | 42/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -0.95 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 3.0% | 32/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.24× | 0/100 |
| Years with positive free cash flow (last 5) | 2 of 5 | 25/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 93.5% | 0/100 |
| Operating margin volatility | 36.3% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 20.4% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 43 | 136 | 188 | 187 | 237 |
| Cost of revenue | 40 | 143 | 164 | 148 | 177 |
| Gross profit | 3.3 | (6.7) | 24 | 39 | 60 |
| Research & development | 5.5 | 4.4 | 2.5 | 1.7 | 1.8 |
| Selling, general & admin | 20 | 27 | 28 | 25 | 28 |
| Operating income | (31) | (35) | 23 | 12 | 23 |
| Interest expense | 0.1 | 7.1 | 2.9 | 1.1 | 3.9 |
| Pre-tax income | (31) | (42) | 25 | 11 | 20 |
| Income tax | (0) | (0) | 0.1 | 0.6 | (11) |
| Net income | (31) | (42) | 25 | 10 | 31 |
| Diluted EPS | −$0.42 | −$3.41 | −$0.10 | $0.34 | $0.84 |
| Diluted shares (millions) | 73 | 12 | 28 | 31 | 36 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
−0.95 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026